Cargando…
Long lasting clinical response to chemotherapy for advanced uterine leiomyosarcoma: a case report
INTRODUCTION: Uterine leiomyosarcoma is one of the most frequent uterine sarcomas. In the metastatic setting it is sensitive to doxorubicin, ifosfamide, gemcitabine, docetaxel and a few other drugs, but time to progression is generally short. For this reason prognosis is often poor and there are few...
Autores principales: | Ridolfi, Claudio, Pasini, Giuseppe, Drudi, Fabrizio, Barzotti, Eleonora, Santelmo, Carlotta, Polselli, Antonio, Ravaioli, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565880/ https://www.ncbi.nlm.nih.gov/pubmed/23347560 http://dx.doi.org/10.1186/1752-1947-7-29 |
Ejemplares similares
-
Lipoplatin Treatment in Lung and Breast Cancer
por: Fantini, Manuela, et al.
Publicado: (2011) -
Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report
por: Bongiovanni, Alberto, et al.
Publicado: (2015) -
Outcomes of First-Line Chemotherapy in Patients with Advanced or Metastatic Leiomyosarcoma of Uterine and Non-Uterine Origin
por: Oosten, A. W., et al.
Publicado: (2009) -
Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report
por: Nteli, Viktoria-Anna, et al.
Publicado: (2018) -
Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022)